Predicted protein targets (top 11)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | DNM1 | Q05193 | 4/20 | 0.44 |
| ▸ | GGPS1 | O95749 | 3/20 | 0.37 |
| ▸ | CA12 | O43570 | 1/20 | 0.35 |
| ▸ | CA1 | P00915 | 1/20 | 0.35 |
| ▸ | CA2 | P00918 | 1/20 | 0.35 |
| ▸ | CA9 | Q16790 | 1/20 | 0.35 |
| ▸ | S1PR2 | O95136 | 1/20 | 0.35 |
| ▸ | S1PR1 | P21453 | 1/20 | 0.35 |
| ▸ | S1PR3 | Q99500 | 1/20 | 0.35 |
| ▸ | S1PR5 | Q9H228 | 1/20 | 0.35 |
| ▸ | GBA1 | P04062 | 1/20 | 0.33 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL18941461 | 0.98 | DNM1 (0.48) | DNM1GGPS1CA12CA1CA2 | |
| SCHEMBL1241227 | 0.98 | DNM1 (0.42) | DNM1GGPS1CA12CA1CA2 | |
| SCHEMBL9161823 | 0.98 | DNM1 (0.48) | DNM1GGPS1CA12CA1CA2 | |
| SCHEMBL1403907 | 0.98 | DNM1 (0.48) | DNM1GGPS1CA12CA1CA2 | |
| SCHEMBL7920911 | 0.98 | DNM1 (0.48) | DNM1GGPS1CA12CA1CA2 | |
| Hydrochloric Acid SCHEMBL28919675 | 0.96 | DNM1 (0.50) | DNM1GGPS1CA12CA1CA2 | |
| SCHEMBL5985979 | 0.93 | DNM1 (0.35) | DNM1CA12CA1CA2CA9 | |
| SCHEMBL1403834 | 0.84 | DNM1 (0.48) | DNM1GGPS1CA12CA1CA2 | |
| SCHEMBL17622993 | 0.82 | — | — | |
| SCHEMBL7528493 | 0.82 | TSHR (0.37) | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 15 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2011132826-A1 | TRANSDERMAL DRUG DELIVERY SYSTEM AND PHARMACEUTICAL COMPOSITION FOR PREVENTING OR TREATING BONE DISEASES | SNU R&DB FOUNDATION (KR) | 2011-10-27 | — | — | WO | claimed |
| WO-2011016738-A1 | A PROCESS FOR THE SYNTHESIS OF 1-HYDROXY-3-(N-METHYLPENTYLAMINO) PROPYLIDENE BISPHOSPHONIC ACID MONOSODIUM SALT, MONOHYDRATE | ZAKLADY FARMACEUTYCZNE POLPHARMA SA (PL) | 2011-02-10 | — | — | WO | claimed |
| EP-2804636-A1 | BONE FILLER COMPOSITION | DePuy International Limited (GB) | 2014-11-26 | — | — | EP | disclosed |
| WO-2013108035-A1 | BONE FILLER COMPOSITION | DEPUY INTERNATIONAL LIMITED (GB) | 2013-07-25 | — | — | WO | disclosed |
| WO-2011016738-A1 | A PROCESS FOR THE SYNTHESIS OF 1-HYDROXY-3-(N-METHYLPENTYLAMINO) PROPYLIDENE BISPHOSPHONIC ACID MONOSODIUM SALT, MONOHYDRATE | ZAKLADY FARMACEUTYCZNE POLPHARMA SA (PL) | 2011-02-10 | — | — | WO | disclosed |
| EP-2120585-A1 | LONG TERM SUSTAINED RELEASE PHARMACEUTICAL COMPOSITION CONTAINING AQUEOUS SUSPENSION OF BISPHOSPHONATE | Amphastar Pharmaceuticals Incorporation (US) | 2009-11-25 | — | — | EP | disclosed |
| WO-2008085281-A1 | LONG TERM SUSTAINED RELEASE PHARMACEUTICAL COMPOSITION CONTAINING AQUEOUS SUSPENSION OF BISPHOSPHONATE | AMPHASTAR PHARMACEUTICALS, INC. (US) | 2008-07-17 | — | — | WO | disclosed |
| EP-1796602-A2 | MULTIFUNCTIONAL COMPOUNDS FOR FORMING CROSSLINKED BIOMATERIALS AND METHODS OF PREPARATION AND USE | Angiotech Pharmaceuticals (US), Inc. (US) | 2007-06-20 | — | — | EP | disclosed |
| WO-2006083260-A2 | COMPOSITIONS AND SYSTEMS FOR FORMING CROSSLINKED BIOMATERIALS AND ASSOCIATED METHODS OF PREPARATION AND USE | ANGIOTECH BIOMATERIALS CORPORATION (US) | 2006-08-10 | — | — | WO | disclosed |
| WO-2006078282-A2 | COMPOSITIONS AND SYSTEMS FOR FORMING CROSSLINKED BIOMATERIALS AND ASSOCIATED METHODS OF PREPARATION AND USE | ANGIOTECH BIOMATERIALS CORPORATION (US) | 2006-07-27 | — | — | WO | disclosed |
| WO-2006034128-A2 | MULTIFUNCTIONAL COMPOUNDS FOR FORMING CROSSLINKED BIOMATERIALS AND METHODS OF PREPARATION AND USE | ANGIOTECH BIOMATERIALS CORPORATION (US) | 2006-03-30 | — | — | WO | disclosed |
| EP-1117412-A1 | COMPOSITIONS CONTAINING DIPHOSPHONIC ACIDS | F. HOFFMANN-LA ROCHE AG (CH) | 2001-07-25 | — | — | EP | disclosed |
| WO-2000021540-A1 | COMPOSITIONS CONTAINING DIPHOSPHONIC ACIDS | F. HOFFMANN-LA ROCHE AG (CH) | 2000-04-20 | — | — | WO | disclosed |
| EP-0850086-A1 | DEVICE FOR THE IONTOPHORETIC ADMINISTRATION OF BISPHOSPHONATES | Becton, Dickinson and Company (US) | 1998-07-01 | — | — | EP | disclosed |
| WO-1997047356-A1 | DEVICE FOR THE IONTOPHORETIC ADMINISTRATION OF BISPHOSPHONATES | BECTON, DICKINSON AND COMPANY (US) | 1997-12-18 | — | — | WO | disclosed |